2026 Chief Revenue Cycle Officer Priorities Snapshot

For CRCOs, the AI conversation is increasingly about ROI. Scaling and achieving ROI on AI investments is CRCOs' number one improvement opportunity — yet it ranks just 16th as a strategic priority. This is revealing gap: revenue cycle leaders clearly believe AI should be delivering measurable value — but many are not yet seeing the returns they expected. In the context of escalating policy risk, payer friction, and pressure to demonstrate financial stewardship, this gap suggests revenue cycle leaders are increasingly scrutinizing their AI investments. For CRCOs, automation is increasingly tied to margin defense — not just modernization.

Revenue cycle leaders are prioritizing automation above all else. Automation of workflows and processes scores 4.7 — tied with CFOs for the highest rating across executive roles 2026_CFO_Priorities_Snapshot. Denials management and prior authorization also rank among CRCOs’ top priorities, both of which are high-volume, rules-based functions well suited to automation. Together, this suggests revenue cycle leaders see technology not as future transformation, but as an immediate operational lever.

Revenue cycle's core functions are performing well, but the patient-facing side lags behind. Maximizing revenue capture and strategic cost management sit firmly in the "strategic strengths" quadrant, reflecting CRCOs' confidence in traditional back-office revenue cycle performance. Meanwhile, patient affordability ranks 20th as a priority but 2nd as an improvement opportunity — the starkest gap on the list. As health systems face growing pressure around price transparency and consumer financial experience, CRCOs have a significant opportunity to extend their influence from back-office optimization into the patient-facing financial journey.